Mr.Rohit Sathe joins the leadership team of Philips India as President – Philips India Healthcare, effective from 4th December 2017.

Philips India has been on a mission of scaling its positioning in the healthcare sector. And the leadership experience and extensive industry knowledge which Rohit brings with him can contribute to Philips’ overall growth plans. 

In his new role, he will oversee key initiatives to improve access to healthcare in the areas of prevention, diagnostics, and treatment. The appointment is set to augment Philips’ leadership position and reinforce its market presence with significant value-addition for customers.

"I am excited about our continued endeavor to provide people with a healthy and improved lifestyle. I look forward to working closely with Daniel and the entire team at Philips, and helping the company achieve its full potential in the Indian market while strengthening relationships with government and other key stakeholders," said Rohit Sathe.

Philips has a target of touching 200 million patients in India by 2025. And in March this year, they had also shared their plan of hiring doctors with domain expertise to co-create healthcare solutions for prevention, diagnosis, and treatment of diseases. They were then looking to increase the workforce by 25 percent in 2017, from 2,500 to 3,125 employees. While it continues its voyage of hiring new employees it has taken a huge step in the direction of growth with this recent appointment for a leadership role. 

Daniel Mazon, Vice Chairman and Managing Director, Philips India happily welcomed Rohit Sathe to the Philps family and said, “Rohit brings a legacy of outstanding customer focused experience and in-depth knowledge of healthcare. I am confident that with his solid background in strategy, commercial execution and his passion for talent development, he will propel Philips India’s growth further across various markets. We will continue to invest in our leaders to ensure we have a strong foundation to support our customers, strategic plans and double-digit growth.”

Prior to this, Rohit was working with Johnson and Johnson Medical India (JJMI) as Senior Director of Strategy, Key Accounts and International (SAARC) Business.  Here he has worked in the Cardiology, Orthopaedics and Neuro segments.

Adding his tenure in JJMI, he has almost two decades of work experience in the healthcare, construction and e-learning industries in both India and UK. Some of his achievements include launching coronary drug-eluting stents (DES), integrating the recently acquired Synthes business into Johnson and Johnson and turning around and improving the profitability of the Trauma and Neuro businesses.

Healthcare in India is expected to become an over $200 billion opportunity by 2020. As Philip India works to maintain its position in this growing healthcare sector and continues to compete with various healthcare startups, this new appointment for a leadership position can play a crucial role.